Catalog No. 

CS739056

Species reactivity

Human

Applications 

Research Grade Biosimilar

Host species

Humanized

Isotype 

IgG1-Kappa

Expression system 

Mammalian Cells

Clonality 

Monoclonal

Target

VSTM3, TIGIT, V-set and transmembrane domain-containing protein 3, VSIG9, V-set and immunoglobulin domain-containing protein 9, T-cell immunoreceptor with Ig and ITIM domains

Concentration 

1mg/ml

Endotoxin level 

Please contact the lab for this information.

Purity 

>95% purity as determined by SDS-PAGE.

Purification 

Protein A/G, purified from cell culture supernatant.

Accession

Q495A1

Form 

Liquid

Storage buffer 

0.01M PBS,pH7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -677°C.

Alternate Names 

BGB-A1217,CAS:2342597-93-5

Background

Ociperlimab is a humanized IgG1 anti-TIGIT antibody. Ociperlimab binds to the extracellular domain of human TIGIT with high affinity (KD = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands PVR or PVR-L2. Ociperlimab can be used in research of cancer.

Note

For research use only. Not for use in clinical or therapeutic applications.